Aimmune Therapeutics, Inc.

www.aimmune.com

USA

8000 Marina Boulevard Suite 300 Brisbane, CA 94005-1884

NASDAQ:AIMT

Aimmune is a clinical-stage biopharmaceutical company with headquarters in the San Francisco Bay Area’s biotechnology center. We are working to lead an emerging therapeutic space and make a profound difference in the lives of people with food allergies by developing and commercializing desensitization treatments for peanut and other food allergies.